Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
Erratum to semaglutide seems to be more effective the other GLP-1Ras [PMID: 29611550] Laboratory literature summary: Erratum to semaglutide seems to be more effective the other GLP-1Ras
Legal Status / FDA Liraglutide is FDA-approved and legally available by prescription in the United States under two brand names: Victoza (approved January 2010): Type 2 diabetes in adults and children aged 10+, dosed at 1.2 to 1.8 mg daily Saxenda (approved December 2014): Chronic weight management in adults with BMI of 30 or greater (or 27+ with a weight-related comorbidity) and adolescents aged 12+ with obesity, dosed at 3.0 mg daily Liraglutide is not a controlled substance and is classified as a prescription medication in all major markets
Look for NSF or USP or Informed Choice for reputable third-party organizations
Platforms like MeAgain centralize tracking and reminders for medication timing, meals, hydration, and symptom notes, helping users turn scattershot habits into consistent, small routines that preserve energy and reduce side effects
US$ 23.41
US$ 26.09
US$ 23.79
US$ 27.85
US$ 21.18
US$ 26.49
